Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice

Phytomedicine

Volumn 14, Issue 7-8, 2007, Pages 523-529

  Chen, Y ^a   Wang, H D ^b   Xia, X ^a   Kung, H F ^c   Pan, Y ^a   Kong, L D ^a  

^a NANJING UNIVERSITY   (China)

^b THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Chronic mild stress; Depression; Mice; Psoralea corylifolia; Total furocoumarins

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; FUROCOUMARIN DERIVATIVE; HYDROCORTISONE; PSORALEA CORYLIFOLIA EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG DOSE COMPARISON; DRUG ISOLATION; ENZYME ACTIVITY; FOOD INTAKE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT SEED; PRIORITY JOURNAL; PSORALEA; PSORALEA CORYLIFOLIA;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; HYDROCORTISONE; LIVER; MALE; MICE; MICE, INBRED ICR; MONOAMINE OXIDASE; PHYTOTHERAPY; PLANT EXTRACTS; PSORALEA; PSORALENS; SEEDS; STRESS; SUCROSE; SUPEROXIDE DISMUTASE;

CULLEN CORYLIFOLIA; MUS;

EID: 34447503250     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.09.007     Document Type: Article

References (32)

1. Abdalla D.S., Monteiro H.P., Oliveira J.A., and Bechara E.J. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin. Chem. 32 (1986) 805-807
2. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., and Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 128 (2005) 1301-1313
3. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., and Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect Dis. 64 (2001) 43-51
4. Chen Y., Kong L.D., Xia X., Kung H.F., and Zhang L. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice. J. Ethnopharmacol. 96 (2005) 451-459
5. Chino M., Sato K., Yamazaki T., and Maitani T. Constituent of natural food additive hokosshi extract and an analytical method for the additive in foods. Shokuhin Eiseigaku Zasshi 43 (2002) 352-355
6. Ciaravi V., McCullough T., and Dayan A.D. Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets. Hum. Exp. Toxicol. 20 (2001) 533-550
7. Cyr M., Calon F., Morissette M., Grandbois M., Di Paolo T., and Callier S. Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curr. Pharm. Des. 6 (2000) 1287-1312
8. Deng K.Y. Determination of psoralen and isopsoralen in Gengnianping capsules by HPLC. Chin. Traditional Patent Med. 23 (2001) 643-645
9. Gareri P., Falconi U., De Fazio P., and De Sarro G. Conventional and new antidepressant drugs in the elderly. Prog. Neurobiol. 61 (2000) 353-396
10. Heuser I.J., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., and Holsboer F. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psych. 153 (1996) 93-99
11. Holsboer F., Lauer C.J., Schreiber W., and Krieg J.C. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62 (1995) 340-347
12. Jiangsu College of New Medicine. The Dictionary of the Traditional Chinese Medicine (1977), Shanghai Press of Science and Technology, Shanghai 1177-1179
13. Kirschbaum C., and Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19 (1994) 313-333
14. Kong L.D., Tan R.X., Woo A.Y., and Cheng C.H.K. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacol. Toxicol. 88 (2001) 75-80
15. Li J.M., Kong L.D., Wang Y.M., Cheng C.H., Zhang W.Y., and Tan W.Z. Behavioral and biochemical studies on chronic mild stress models in rats treated with a Chinese traditional prescription Banxia-houpu decoction. Life Sci. 74 (2003) 55-73
16. Lukash A.I., Zaika V.G., Kucherenko A.O., and Miliutina N.P. Free radical processes and antioxidant system in depression and treatment efficiency. Zh Nevrol Psikhiatr Im S S Korsakova 102 (2002) 41-44
17. Ma Z.Q., Violani E., Villa F., Picotti G.B., and Maggi A. Estrogenic control of monoamine oxidase a activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor. Eur. J. Pharmacol. 284 (1995) 171-176
18. Monleon S., D'Aquila P., Parra A., Simon V.M., Brain P.F., and Willner P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berl) 117 (1995) 453-457
19. Partonen T. Psoralens in association with seasonal affective disorder. Med. Hypotheses 50 (1998) 481-482
20. Poirier M.F., Loo H., Mitrani N., Benkelfat C., Askienazy S., and Le Fur G. Platelet MAO activity in clinical subtypes of depression and DST suppression. Acta Psychiatr. Scand. 75 (1987) 456-463
21. Quitkin F.M., McGrath P.J., Stewart J.W., Taylor B.P., and Klein D.F. Can the effects of antidepressants be observed in the first two weeks of treatment?. Neuropsychopharmacology 15 (1996) 390-394
22. Schule C., Baghai T.C., Eser D., Zwanzger P., Jordan M., Buechs R., and Rupprecht R. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology (Berl) 186 (2006) 601-611
23. Schurr A., and Livne A. Different inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochem. Pharmacol. 25 (1976) 1201-1203
24. Stewart D.E., Rolfe D.E., and Robertson E. Depression, estrogen, and the Women's Health Initiative. Psychosomatics 45 (2004) 445-447
25. Tiemeier H. Biological risk factors for late life depression. Eur. J. Epidemiol. 18 (2003) 745-750
26. van Heeringen K., Audenaert K., Van de Wiele L., and Verstraete A. Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity. J. Affect. Disord. 60 (2000) 181-189
27. Wheeler C.R., Salzman C.A., Elsayed N.M., Omaye S.T., and Korte D.W. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal. Biochem. 184 (1990) 193-199
28. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 16 (1992) 525-534
29. Wouters J. Structural aspects of monoamine oxidase and its reversible inhibition. Curr. Med. Chem. 5 (1998) 137-162
30. Yagi K. Lipid peroxides and related radicals in clinical medicine. Adv. Exp. Med. Biol. 366 (1994) 1-15
31. Yu Z.F., Kong L.D., and Chen Y. Antidepressant activity of aqueous extracts of Curcuma longa. J. Ethnopharmacol. 83 (2002) 161-165
32. Zhang C.Z., Wang S.X., Zhang Y., Chen J.P., and Liang X.M. In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. J. Ethnopharmacol. 98 (2005) 295-300